Bhagiradha Chemicals & Industries Limited Business Intelligence Report
Bhagiradha Chemicals & Industries Limited Business Intelligence Report
Quality Scores
Latest Quarterly Earnings Summary
Loading latest quarter…
AI Summary
Bhagiradha Chemicals & Industries Limited is an established agrochemical player with a specialized portfolio of 32 active ingredients, including insecticides like Chlorpyrifos and Fipronil. Over the last decade, the business has evolved from a small-scale manufacturer to a significant technical player with a market cap of approximately ₹3,876 Cr. While the company exhibits strong historical stock price compounding, its recent financial performance has been characterized by high capital intensity and margin volatility. The business is currently in a heavy CAPEX phase, evidenced by Fixed Assets…
Key Changes in FY2026
The business has evolved from a niche scientist-led technical manufacturer in 1993 to a scaled player with 32 active ingredients across insecticides, fungicides, and herbicides. The timeline shows a distinct shift around 2023-2024, moving from a stable, low-debt model to a high-capex, high-growth trajectory evidenced by the jump in fixed assets from ₹173 Cr to ₹580 Cr in three years. Expansion into specialty intermediates like R-HPPA and 2,6-Dichloroaniline indicates a move up the value chain to reduce dependency on generic agrochemical cycles. Digital transformation and R&D focus are evident in the broadening product portfolio. The transition from ₹246 Cr sales in 2020 to a TTM of ₹607 Cr represents a successful scaling of the technical manufacturing platform.
Management Commentary
Management, originally led by former IICT scientists, maintains a strong technical focus on complex chemistries like R-HPPA and 2,6-Dichloroaniline. Their communication is transparent via regular concalls and investor presentations, though they have struggled to maintain margins during the recent agrochemical downturn. A significant watch area is the low promoter holding, which has decreased from 24.9% to 19.6% over the last few years, raising questions about long-term skin in the game. Despite this, the execution of the large-scale CAPEX project shows management's ambition to move up the value chain. The alignment between management's growth narrative and the resulting balance sheet stress remains a critical monitorable.
Financial Highlights
The business has demonstrated significant revenue growth, doubling sales from ₹246 Cr in 2020 to ₹536 Cr in 2026, with TTM figures reaching ₹607 Cr. However, profit growth has not kept pace, with PAT falling from ₹45 Cr in 2023 to ₹18 Cr in 2026, leading to a negative 5-year profit CAGR of -4%. Operating margins (OPM) have been highly volatile, peaking at 16% in 2022 before compressing to 8% in 2025, reflecting sensitivity to raw material prices and global dumping pressures. Interest costs have spiked from ₹5 Cr in 2023 to ₹17 Cr in 2026 due to increased borrowings for expansion. The current P/E of 141x appears disconnected from current earnings, suggesting the market is pricing in a massive recovery from new capacities.
Major Opportunities
- Significant revenue recovery in TTM and FY26
- Extensive product portfolio with 32 active ingredients
- Strong historical stock price CAGR performance
Major Risks
- Critically low promoter holding at 19.6%
- Poor 5-year sales growth CAGR of 11%
- Consistent negative Free Cash Flow for 6 years
About Bhagiradha Chemicals & Industries Limited's Annual Report & Financial Performance
The latest Bhagiradha Chemicals & Industries Limited annual report (FY2026) is the company's flagship annual disclosure, filed with NSE / BSE. It covers the full-year business review, management discussion & analysis, audited financial statements, the director's report, the corporate governance and auditor's reports, risk factors, capital allocation, subsidiaries, related-party transactions and ESG initiatives. This Business Intelligence Hub consolidates the official filings with AI-generated financial analysis so investors can see how revenue, operating margin, cash flow quality, capex, dividends, net debt and management outlook have changed — without reading the entire filing.
What this Bhagiradha Chemicals & Industries Limited research covers
- Fundamental & business analysis
- Financial statements & performance
- Management commentary & discussion
- Corporate governance & auditor report
- Cash flow analysis & capital allocation
- Valuation analysis & business quality
- Growth analysis & competitive position
- Risk, SWOT & moat analysis
- Quarterly earnings & conference-call summary
- Sector, industry & peer comparison
- Latest official company filings
- Business outlook & long-term growth
Bhagiradha Chemicals & Industries Limited — Frequently Asked Questions
Explore more Bhagiradha Chemicals & Industries Limited research
AI Top Insights — Premium
Unlock deeper AI Top Insights, advanced comparisons, downloadable reports and premium features.